Serum per- and polyfluoroalkyl substances and abnormal lipid metabolism: A nationally representative cross-sectional study

Background: The associations of legacy per- and polyfluoroalkyl substances (PFAS) with lipid metabolism are controversial, and there is little information about the impact of emerging PFAS (6:2 Cl-PFESA) on lipid metabolism in China. Objectives: We aimed to explore the associations of legacy and eme...

Full description

Bibliographic Details
Published in:	Environment International
Main Authors:	Bing Wu, Yitao Pan, Zheng Li, Jinghua Wang, Saisai Ji, Feng Zhao, Xiaochen Chang, Yingli Qu, Yuanduo Zhu, Linna Xie, Yawei Li, Zheng Zhang, Haocan Song, Xiaojian Hu, Yidan Qiu, Xulin Zheng, Wenli Zhang, Yanwei Yang, Heng Gu, Fangyu Li, Jiayi Cai, Ying Zhu, Zhaojin Cao, John S.Ji, Yuebin Lv, Jiayin Dai, Xiaoming Shi
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Subjects:	Per- and polyfluoroalkyl substances (PFAS) Emerging per-/polyfluoroalkyl substances Lipid profiles Dyslipidemia China National Human Biomonitoring
Online Access:	http://www.sciencedirect.com/science/article/pii/S0160412023000521

Similar Items

Hunting Metabolic Biomarkers for Exposure to Per- and Polyfluoroalkyl Substances: A Review
by: Xue Ma, et al.
Published: (2024-07-01)

Integration of ultrashort-chain compounds into the biomonitoring of per- and polyfluorinated substances in human plasma and serum
by: Shun-Hsin Liang, et al.
Published: (2024-05-01)

Associations of per- and polyfluoroalkyl substances (PFAS) and their mixture with risk of rheumatoid arthritis in the U.S. adult population
by: Jian-Chao Qiao, et al.
Published: (2024-04-01)

Associations of per-/polyfluoroalkyl substances with glucocorticoids and progestogens in newborns
by: Hongxiu Liu, et al.
Published: (2020-07-01)

Associations between serum per- and polyfluoroalkyl substances and thyroid hormones in Chinese adults: A nationally representative cross-sectional study
by: Yanan Xing, et al.
Published: (2024-02-01)

Exposure to per- and polyfluoroalkyl substances and high-throughput proteomics in Hispanic youth
by: Jiawen Carmen Chen, et al.
Published: (2024-04-01)

Per- and polyfluoroalkyl substances alter innate immune function: evidence and data gaps
by: Drake W. Phelps, et al.
Published: (2024-12-01)

An insight into the environmental and human health impacts of per- and polyfluoroalkyl substances (PFAS): exploring exposure pathways and their implications
by: Mohammad Hadi Dehghani, et al.
Published: (2025-06-01)

Overview of Per- and Polyfluoroalkyl Substances (PFAS), Their Applications, Sources, and Potential Impacts on Human Health
by: Zunaira Habib, et al.
Published: (2024-03-01)

Advances in per- and polyfluoroalkyl substances (PFAS) detection and removal techniques from drinking water, their limitations, and future outlooks
by: Zahra Zahra, et al.
Published: (2025-03-01)

Towards a Better Understanding of the Human Health Risk of Per- and Polyfluoroalkyl Substances Using Organoid Models
by: Haoan Xu, et al.
Published: (2025-04-01)

Effects of Per- and Polyfluoroalkylated Substances on Female Reproduction
by: María Estefanía González-Alvarez, et al.
Published: (2024-06-01)

Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults
by: Xinyuan Zhang, et al.
Published: (2023-05-01)

Prenatal per- and polyfluoroalkyl substances exposure and gut microbiota of infants: A prospective cohort study
by: Honglei Ji, et al.
Published: (2024-01-01)

Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease
by: Linda Dunder, et al.
Published: (2023-07-01)

Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease – Results from two independent population-based cohorts and a meta-analysis
by: Linda Dunder, et al.
Published: (2023-11-01)

Individual and mixtures of PFAS during pregnancy are associated with maternal cardiometabolic outcomes during pregnancy
by: Clark R. Sims, et al.
Published: (2025-04-01)

Legacy and emerging per- and polyfluoroalkyl substances suppress the neutrophil respiratory burst
by: Drake W. Phelps, et al.
Published: (2023-12-01)

Landfill leachate treatment process is transforming and releasing banned per- and polyfluoroalkyl substances to UK water
by: Pippa Neill, et al.
Published: (2024-11-01)

Per and polyfluoroalkyl substances affect thyroid hormones for people with a history of exposure from drinking water
by: Taylor S. Noyes, et al.
Published: (2025-04-01)

Association of per- and polyfluoroalkyl substances with gout risk: a cross-sectional analysis of NHANES 2007–2018 data emphasizing mixture effects
by: Haixin Feng, et al.
Published: (2025-02-01)

First trimester plasma PER- AND Polyfluoroalkyl Substances (PFAS) and blood pressure trajectories across the second and third trimesters of pregnanacy
by: Jordan A. Burdeau, et al.
Published: (2024-04-01)

Association between per- and polyfluoroalkyl substances and unexplained recurrent spontaneous abortion: A case-control study in China
by: Qianxi Cheng, et al.
Published: (2025-08-01)

Associations between maternal exposure to per- and polyfluoroalkyl substances and childhood neurodevelopment up to age 4: The Japan environment and children’s study
by: Hidetoshi Mezawa, et al.
Published: (2025-10-01)

Association between exposure to bisphenols and per- and polyfluoroalkyl substances and behavioral problems among Chinese preschoolers
by: Ruo-yu Li, et al.
Published: (2025-09-01)

The effect of PFAS exposure on glucolipid metabolism in children and adolescents: a meta-analysis
by: Qingqing Zheng, et al.
Published: (2024-02-01)

Exposure to Per- and Polyfluoroalkyl Substances and Risk of Psoriasis: A Population-Based Study
by: Qing Zhang, et al.
Published: (2024-11-01)

The association between per- and polyfluoroalkyl substances and biological aging among middle and older age adults: The moderating effect of caffeine
by: Shuxiang Yan, et al.
Published: (2025-09-01)

Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights
by: George Briassoulis, et al.
Published: (2025-07-01)

Crop Contamination and Human Exposure to Per- and Polyfluoroalkyl Substances around a Fluorochemical Industrial Park in China
by: Kairan Xu, et al.
Published: (2024-04-01)

Associations of perfluoroalkyl substances (PFAS) with terminal ductal lobular unit involution of the normal breast
by: Katherine W. Reeves, et al.
Published: (2025-08-01)

Bone mass density following developmental exposures to perfluoroalkyl substances (PFAS): a longitudinal cohort study
by: Annelise Blomberg, et al.
Published: (2022-11-01)

A Review of Research Advances on Treatment Technologies for Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater
by: Manlin LUO, et al.
Published: (2025-07-01)

Association between serum per- and polyfluoroalkyl substances and thrombograms in young and middle-aged Taiwanese populations
by: Chien-Yu Lin, et al.
Published: (2022-05-01)

Per- and Polyfluoroalkyl Substances (PFAS) in Community Water Systems (CWS) and the Risk of Thyroid Cancer: An Ecological Study
by: Mathilda Alsen, et al.
Published: (2023-09-01)

Per- and polyfluorinated substances (PFAS) promote osteoclastogenesis and bone loss through PPARα activation
by: Laimar C. Garmo, et al.
Published: (2025-12-01)

PFAS: The Journey from Wonder Chemicals to Environmental Nightmares and the Search for Solutions
by: Duwage C. Perera, et al.
Published: (2024-09-01)

Association of exposure to per- and polyfluoroalkyl substances with hemoglobin and hematocrit during pregnancy
by: Fengzhen Cui, et al.
Published: (2022-12-01)

A Review of Research Progress on the Preparation and Analytical Methods of Per- and Polyfluoroalkyl Substances in Groundwater
by: Liqiang GONG, et al.
Published: (2025-07-01)

Association between per- and polyfluoroalkyl substances exposure and childhood obesity: an umbrella review
by: Randy Howard Brataatmaja, et al.
Published: (2025-10-01)